IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 66.79

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.11M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-03 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.63% 81% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.63% 81% B- 70% C-
Trailing 12 Months  
Capital Gain 3.74% 81% B- 58% F
Dividend Return 1.01% 88% B+ 21% F
Total Return 4.76% 81% B- 50% F
Trailing 5 Years  
Capital Gain 34.30% 67% D+ 49% F
Dividend Return 9.12% 95% A 20% F
Total Return 43.42% 71% C- 41% F
Average Annual (5 Year Horizon)  
Capital Gain 2.90% 67% D+ 48% F
Dividend Return 4.28% 67% D+ 44% F
Total Return 1.38% 100% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.31% 62% D 67% D+
Risk Adjusted Return 29.91% 67% D+ 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike